• Home
  • Custom Services - Viral Stock Production

CUSTOM AND OFF THE SHELF VIRUS STOCKS

For Research, Antiviral Screening, Validation Studies, Limit of Detection, Assay Development and Beyond


Virus stocks play a critical role in the development of antiviral drugs, vaccines, biopharmaceuticals and diagnostic technologies that help combat viral threats and protect public health globally. Virologists rely on well characterized, highly purified virus stocks to ensure the validity and integrity of their drug screening, efficacy testing, mechanism of action studies, assay development and more. As pioneers in infectious disease materials and assay services, Microbiologics remains the industry’s trusted source for custom and off-the-shelf virus stock production.


From the household names like Influenza to emerging threats like Dengue, we work with a broad portfolio of infectious agents. We are known for our expertise in both cell-based and egg-based propagation of viruses. Additionally, we offer reverse genetics services, enabling intentional modifications to existing genes or the introduction of new genes not typically found in the viruses.


Whether you're seeking off-the-shelf or made-to-order materials, Microbiologics is your trusted partner for virus stocks. Our offerings include:

  • Crude and purified virus
  • Infectious and inactivated virus
  • High titer virus
  • ddPCR quantification
  • Sequencing
  • Virus models to support adventitious virus screening
  • Recombinant virus
  • Virus banking
  • Cell banking
  • Viral RNA and DNA



CUSTOM VIRUS STOCKS

We offer the most extensive customization options for virus production, ensuring our partners receive a final product that meets their specific needs. Our team of approachable experts will work with you, providing guidance where and when you need it throughout each project. With state-of-the-art facilities, advanced technologies and a highly skilled team, we can customize virtually any aspect of the virus stock production process from choice of host cells and culture conditions to purification, titration, inactivation or attenuation.


All our virus stocks are produced at Microbiologics' Global Virology Center in San Diego which encompasses multiple BSL-2 and BSL-3 laboratories. This facility operates under a Quality Management System that has received ISO 13485 certification. Below are just a few examples of the viruses we have in our vast library of viruses. We can also source additional virus species of interest if needed, or if you already have your own strain, we can further support your research needs.


Influenza A & B

Avian Influenza*

Respiratory Syncytial Virus

SARS-CoV-2

Chickungunya

Dengue

Cytomegalovirus

Adenovirus



Herpesvirus

HIV

hMPV

MVM

Rhinovirus

Varicella-Zoster Virus

West Nile

Zika



*multiple strains available



Avian Influenza

Reassortant LPAI H5N1 - Clade 2.3.4.4b

  • HPAI H5 HA ectodomain polybasic site removed (now LPAI)
  • BSL-2 biosafety level – no BSL-3 or Select Agent requirements
  • Live or Inactivated ready-to-use format for diagnostic and assay research and development

MS-2 Phage protected HPAI H5N1 RNA (pRNA) - Clade 2.3.4.4b

  • Segment of HA gene (A/Texas/37/2024) encapsidated in MS-2 phage
  • BSL-1 biosafety level
  • Molecular assay target control

Looking for deeper support in avian influenza research? Visit our page on Avian Flu Viral Stocks and Laboratory Testing Services to learn more about how our team can help advance your studies.





HIGH-TITER OFF-THE-SHELF (OTS) VIRUS STOCKS

Microbiologics off-the-shelf virus stocks provide convenience and reliability. With our extensive selection readily available for immediate shipment, you have swift access to the strains you need to keep your projects moving forward. Our virus stocks boast the highest titers and copy numbers in the industry, ensuring optimal performance in your research or diagnostic applications. Confidently advance your work with Microbiologics' off-the-shelf virus stocks at your fingertips.


COMMONLY REQUESTED VIRUS STRAINS AVAILABLE OFF-THE-SHELF

Adenovirus 3

Adenovirus 5

Adenovirus 7

Adenovirus 40

Avian Influenza - LP/HP (see list below)

Bovine Viral Diarrhea Virus (BVDV)

Chikungunya

Cytomegalovirus*

Coronavirus 229E

Coronavirus OC43

Coxsackievirus*

Dengue Virus 1-4

Echovirus*

Enterovirus*

Epstein-Barr Virus (EBV)

Epstein-Barr Virus (GFP-tagged)

Herpes Simplex Virus 1*

Herpes Simplex Virus 2*

Hepatitis C Virus (HCV)

HIV 1 & 2

Influenza A (see list below)

Influenza B (see list below)

Measles

Mpox

Parainfluenza 1-5

Poliovirus

Porcine Circovirus 1 (PCV-1)

Reovirus 3

Respiratory Syncytial Virus (RSV-A ON1)

Rhinovirus (HRV-A)

Rhinovirus (HRV-B)

Respiratory Syncytial Virus A*

Respiratory Syncytial Virus B*

SARS-CoV-2* (see list below)

West Nile Virus

Zika



*Multiple strains are available. Submit a contact form below to request details.



2025-2026 WHO Recommended Influenza A/B Egg and/or Cell-Based Vaccine Strains

A/Victoria/4897/2022 (H1N1)

A/Wisconsin/67/2022 (H1N1)*

B/Austria/1359417/2021 (B/Victoria lineage)

A/Croatia/10136RV/2023 (H3N2)

A/District of Columbia/27/2023 (H3N2)*


Influenza A strains available

A/Bangladesh/2021/2012 (H1N1)

A/Beijing/262/1995 (H1N1)

A/Brisbane/02/2018 (H1N1)

A/Brisbane/59/2007 (H1N1)

A/California/4/2009 (H1N1)

A/California/07/2009 (H1N1)

A/California/07/2009 X-181 (H1N1)

A/Guangdong-Maonan/SWL1536/2019 (H1N1)

A/Hawaii/70/2019 (H1N1)

A/Hunan/42443/2015 (H1N1)

A/Michigan/45/2015 (H1N1)

A/Nebraska/14/2018 (H1PDM09) (H1N1)

A/New Caledonia/20/1999 (H1N1)

A/Ohio/09/2015 (H1N1)

A/Puerto Rico/08/1934 (H1N1)

A/Victoria/2570/2019 (H1N1)

A/Wisconsin/588/2019 (H1N1)

A/Wisconsin/67/2022 (H1N1)

A/WSN/1933 (H1N1)

A/Brisbane/1/2018 X-311 (H3N2)

A/California/07/2004 (H3N2)

A/California/123/2022 (H3N2)

A/California/45/2023 (H3N2)

A/Cambodia/e0826360/2020 (H3N2)

A/Darwin/06/2021 (H3N2)

A/Darwin/09/2021 (H3N2)

A/Hong Kong/2671/2019 (H3N2)

A/Hong Kong/4801/2014 (H3N2)

A/Johannesburg/33/1994 (H3N2)

A/Kansas/14/2017 (H3N2)

A/Massachusetts/18/2022 (H3N2)*

A/Perth/16/2009 (H3N2)

A/Port Chalmers/1/1973 (H3N2)

A/Singapore/INFIMH-16-0019/2016 (H3N2)

A/South Australia/34/2019 IVR-197 (H3N2)

A/South Australia/55/2014 (H3N2)

A/Stockholm/06/2014 (H3N2)

A/Switzerland/9715293/2013 (H3N2)

A/Tasmania/503/2020 (H3N2)

A/Texas/50/2012 (H3N2)

A/Thailand/8/2022 (H3N2)

A/Victoria/03/1975 (H3N2)

A/Victoria/361/2011 (H3N2)

A/Wisconsin/67/2005 (H3N2)

A/Wuhan/359/1995 (H3N2)

A/X31 (H3N2)


Influenza B strains available

B/Lee/1940

B/Austria/1359417/2021 (B/Victoria)

B/Brisbane/60/2008 (B/Victoria)

B/Colorado/06/2017 (B/Victoria)

B/Connecticut/01/2021 (B-Victoria)

B/Hong Kong/330/2001 (B/Victoria)

B/Malaysia/2506/2004 (B/Victoria)

B/Maryland/01/1959 (B/Victoria)

B/Maryland/15/2016 (B/Victoria)

B/Nevada/03/2011 (B/Victoria)

B/Washington/02/2019 (B/Victoria)

B/Brisbane/09/2014 (B/Yamagata)

B/Massachusetts/02/2012 (B/Yamagata)

B/Phuket/3073/2013 (B/Yamagata)

B/Victoria/504/2000 (B/Yamagata)

B/Wisconsin/01/2010 (B/Yamagata)



* Designates cell-based strains


Please note, availability of in-stock strains is subject to change without notice. Strains on this list may or may not be immediately available. If the strain you need is not currently in our inventory, our team of experts is ready to get started in making the viral stocks you need.



SARS-COV-2 ISOLATE

hCoV-19/USA/WA1/2020

hCoV-19/Hong Kong/VM20001061/2020

hCoV-2/Italy-INMI1

hCoV-2/USA-CA3/2020

hCoV-2/USA-CA4/2020

hCoV-2/USA-WI1/2020

hCoV-19/MBL-MA1/2020

hCoV-19/USA/CA_CDC_5574/2020

hCoV-2/England/204820464/2020

hCoV-2/South Africa/KRISP-EC-K005321/2020

hCoV-2/South Africa/KRISP-EC-K005325/2020

hCoV-19/USA/MD-HP01542/2021

hCoV-2/Japan/TY7-503/2021**

hCoV-19/USA/PHC658/2021

hCoV-19/USA/MD-HP05285/2021

hCoV-19/USA/CA-VRLC086/2021

hCoV-19/USA/MD-HP05285/2021

hCoV-2/Peru/un-CDC-2-4069945/2021

hCoV-19/USA/MD-HP20874/2021

hCoV-19/USA/CO-CDPHE-2102544747/2021

hCoV-19/USA/CO-CDPHE-2102544747/2021

hCoV-19/USA/NY-MSHSPSP-PV56475/2022

hCoV-19/Japan/TY41-716/2022

hCoV-19/USA/MD-HP30386/2022

hCoV-19/USA/MD-HP35538/2022

hCoV-19/South Africa/CERI-KRISP-K040013/2022

hCoV-19/USA/COR-22-063113/2022

hCoV-19/USA/MD-HP34985/2022

hCoV-19/USA/MD-HP38288/2022

hCoV-19/USA/MD-HP38861/2022

hCoV-19/USA/CA-Stanford-109_S21/2022

hCoV-19/USA/MD-HP40900/2022

hCoV-19/USA/MD-HP41275/2022

hCoV-19/USA/CA-Stanford-139_S23/2023

hCoV-19/USA/New York/PV96109/2023

PANGO LINEAGE

A

A

Identified as Clade “O”

B

B

B

B.1

B.1.1.7

B.1.1.7

B.1.351

B.1.351

B.1.351

P.1

B.1.617.2

B.1.617.2

AY.1

AY.24

C.37

B.1.1.529, BA.1

B.1.1.529, BA.2

B.1.1.529, BA.2.12.1

B.1.1.529, BA.2.12.1

B.1.1.529, BA.2.75

B.1.1.529, BA.4

B.1.1.529, BA.4.6

B.1.1.529, BA.5

B.1.1.529, BA.5

B.1.1.529, BF.5 (BA.5 like)

B.1.1.529, BF.7

B.1.1.529, BQ.1.1

B.1.1.529, XBB

B.1.1.529, XBB.1.5

B.1.1.529, CH.1.1

B.1.1.529, XBB.1.16

B.1.1.529, JN.1

WHO LABEL

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Alpha

Alpha

Beta

Beta

Beta

Gamma

Delta

Delta

Delta

Delta

Lambda

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron

Omicron



**This reagent was obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate hCoV-19/Japan/TY7-503/2021(Brazil P.1), NR-54982, contributed by National Institute of Infectious Diseases.


Please note, availability of in-stock strains is subject to change without notice. Strains on this list may or may not be immediately available. If the strain you need is not currently in our inventory, our team of experts is ready to get started in making the viral stocks you need.






PURIFIED VIRAL STOCK FOR ADVENTITIOUS AGENT DETECTION

Biopharmaceutical manufacturers rely on adventitious virus testing to ensure products are free of contaminants that could harm patients or compromise quality. We are proud to be the industry’s leading experts and go-to collaborators for the broadest portfolio of off-the-shelf and custom virus stock solutions to support Viral Safety and Viral Clearence testing. Whether you're seeking ready-to-use solutions or tailored formulations, Microbiologics is your trusted partner in safeguarding the integrity of your biopharmaceutical products.


Looking for readily available purified stock or custom product? Check out our Viral Safety Solutions for more information on Viral Stock and NGS sequencing.



RECOMBINANT VIRUS

We specialize in generating recombinant virus stocks to advance the research and development of antiviral drugs, therapeutics, and vaccines. Applications for recombinant virus include the generation of vaccine candidates, rapid vaccine development, high-throughput screening for vaccine efficacy, and assay development including virus neutralization, antiviral screening and pathogenicity studies. Our reverse genetics methods allow for precise modifications, such as desired mutations or deletions/additions of viral genes. For example, a BSL-2 virus can be engineered to express glycoproteins from other viruses, including BSL-3 viruses. We have expertise in designing reverse genetics systems for Influenza A and B and more. If you are unsure which viral system is right for your research, our skilled virologists are happy to provide guidance and recommendations.



WHY PARTNER WITH MICROBIOLOGICS

Extensive Portfolio: We are proud to be the industry’s trusted source for live, inactivated, and recombinant viruses. Our diverse portfolio encompasses hundreds of fully characterized viral strains. We offer the highest titer and copy number viral stock materials in the industry, making them ideal for a wide range of applications, spiking into matrixes, or creating different dilutions as needed.


Unparalleled Customization: Whether you’re using cell-based assays, PCR, NGS, ELISA, in-vivo models or other methodologies, we offer extensive customization options, helping our clients design viral stocks to meet their exact requirements. Examples include purified material, single-use aliquots, multi-target stocks, and pre-spiking into your own cell-line. Our team is also skilled at applying reverse genetics methods to design and produce recombinant viruses.


Scalable Supply: Whether you need large quantities for high-throughput screening and assay development, or smaller volumes for validation and LOD studies, we've got you covered. With our scalable capabilities, we can accommodate orders of any size, ensuring you have a steady and reliable source of viral material to support your ongoing activities.


Stringent Quality Assurance: Quality is at the core of everything we do. All our virus stocks undergo rigorous testing procedures to ensure the highest standards of quality and reliability. From initial culturing to final distribution, every step of the production process is meticulously monitored and evaluated to guarantee consistency and performance.


Approachable Experts: Partnering with Microbiologics means gaining access to a team of friendly and trusted experts who are committed to supporting their fellow scientists with virology superior products and services, unmatched customization options, and exceptional customer experiences. We would love to collaborate and advance science for a safer, healthier world together.






Let's Chat About Your Viral Stock Needs

Request a call or virtual meeting with our experts.

Business Development Team
Phone: +1.800.599.2847
Email: businessdevelopment@microbiologics.com